Regeneron Pharmaceuticals Ownership | Who Owns Regeneron Pharmaceuticals?

Overview Forecast RevenueFinancials Chart Transcripts

Regeneron Pharmaceuticals Ownership Summary

Regeneron Pharmaceuticals is owned by 79.24% institutional investors, 1.67% insiders, and 19.09% retail investors. Vanguard group is the largest institutional shareholder, holding 8.59% of REGN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.14% of its assets in Regeneron Pharmaceuticals shares.

REGN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Regeneron Pharmaceuticals	79.24%	1.67%	19.09%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	9.29M	8.59%	$6.61B
Blackrock funding, inc. /de	8.73M	8.08%	$6.22B
Blackrock	8.45M	7.84%	$8.88B
Fmr	8.20M	7.59%	$5.84B
Jpmorgan chase	7.06M	6.53%	$5.03B
State street	4.84M	4.49%	$5.09B
Capital investors	4.74M	4.38%	$3.37B
Capital world investors	2.78M	2.57%	$1.98B
Geode capital management	2.43M	2.25%	$1.73B
Dodge & cox	2.32M	2.15%	$1.65B

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bronte capital management pty	152.78K	10.09%	$127.84M
Cutter capital management, lp	31.50K	9.19%	$22.44M
Orion investment	29.89K	8.49%	$21.29M
Mcdonald capital investors inc/ca	170.18K	7.61%	$121.22M
Rk asset management	9.99K	5.82%	$7.12M
R.p. boggs	9.28K	3.94%	$6.61M
Krensavage asset management	7.85K	3.79%	$8.25M
Ellerson group inc /adv	6.92K	3.60%	$4.93M
Guoline advisory pte	46.36K	3.41%	$33.02M
Rhenman & partners asset management ab	43.46K	3.18%	$30.96M

Top Buyers

Holder	Shares	% Assets	Change
Capital investors	4.74M	0.63%	1.39M
Norges bank	1.13M	0.11%	1.13M
Price t rowe associates inc /md/	2.09M	0.17%	810.14K
Loomis sayles & co l p	1.58M	1.42%	394.00K
Qube research	441.65K	0.41%	289.69K

Top Sellers

Holder	Shares	% Assets	Change
Fmr	8.20M	0.35%	-2.16M
Capital world investors	2.78M	0.30%	-1.52M
International assets investment management	566.00	0.03%	-880.37K
Capital research global investors	-	-	-644.87K
Massachusetts financial services co /ma/	15.23K	0.00%	-499.03K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	1.13M	0.11%	1.13M	$802.04M
Voloridge investment management	212.13K	0.53%	212.13K	$151.11M
Raymond james financial	91.50K	0.02%	91.50K	$65.18M
Cubist systematic strategies	39.69K	0.18%	39.69K	$28.27M
Distillate capital partners	32.14K	1.13%	32.14K	$22.89M

Sold Out

Holder	Change
Proffitt & goodson	-1.00
Tfo-tdc	-1.00
Triad wealth partners	-1.00
Financial gravity asset management	-1.00
Institutional & family asset management	-1.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	1,243	-13.68%	85,658,993	-7.35%	79	1.08%	578	-12.82%	435	-4.81%
Sep 30, 2024	1,416	2.98%	92,708,421	-1.26%	85	1.14%	652	-1.06%	448	4.92%
Jun 30, 2024	1,358	-0.29%	93,841,367	2.15%	87	1.20%	650	4.67%	422	-5.59%
Mar 31, 2024	1,362	3.34%	91,870,569	0.66%	85	1.16%	621	1.31%	447	0.68%
Dec 31, 2023	1,318	7.15%	91,271,963	0.24%	85	1.17%	613	21.15%	444	0.23%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	3.44M	3.14%	178.74K
Vanguard Total Stock Mkt Idx Inv	3.41M	3.12%	12.88K
Vanguard Institutional 500 Index Trust	2.92M	2.67%	19.58K
Invesco QQQ Trust	2.21M	2.03%	-1.93K
Capital Group Growth Fnd of Amer Comp	2.09M	1.90%	-1.04M
American Funds Growth Fund of Amer A	2.09M	1.90%	-1.04M
Fidelity Contrafund	2.08M	1.90%	-23.90K
Dodge & Cox Stock I	1.55M	1.41%	-1.50K
Capital Group New Perspective Comp	1.48M	1.36%	185.61K
American Funds New Perspective A	1.48M	1.35%	185.61K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 01, 2024	McCourt Marion	EVP Commercial	Sell	$844.61K
Oct 01, 2024	RYAN ARTHUR F	-	Sell	$5.22K
Oct 01, 2024	RYAN ARTHUR F	-	Sell	$9.40K
Oct 01, 2024	RYAN ARTHUR F	-	Sell	$7.32K
Oct 01, 2024	RYAN ARTHUR F	-	Sell	$1.04K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q4	-	19
2024 Q3	-	117
2024 Q2	-	113
2024 Q1	-	116

REGN Ownership FAQ

Who Owns Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals shareholders are primarily institutional investors at 79.24%, followed by 1.67% insiders and 19.09% retail investors. The average institutional ownership in Regeneron Pharmaceuticals's industry, Biotech Stocks , is 68.48%, which Regeneron Pharmaceuticals exceeds.

Who owns the most shares of Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals’s largest shareholders are Vanguard group (9.29M shares, 8.59%), Blackrock funding, inc. /de (8.73M shares, 8.08%), and Blackrock (8.45M shares, 7.84%). Together, they hold 24.50% of Regeneron Pharmaceuticals’s total shares outstanding.

Does Blackrock own Regeneron Pharmaceuticals?

Yes, BlackRock owns 7.84% of Regeneron Pharmaceuticals, totaling 8.45M shares as of Jun 2024. This represents 0.20% of BlackRock's total assets, with a market value of 8.88B$. In the last quarter, BlackRock decreased its holdings by -122K shares, a -1.43% change.

Who is Regeneron Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bronte capital management pty is Regeneron Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 10.09% of its assets in 152.78K Regeneron Pharmaceuticals shares, valued at 127.84M$.

Who is the top mutual fund holder of Regeneron Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Regeneron Pharmaceuticals shares, with 3.14% of its total shares outstanding invested in 3.44M Regeneron Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools